Alkermes' narcolepsy drug meets main goal in a mid-stage trial

Core Insights - Alkermes announced that its experimental drug for narcolepsy successfully met the primary objectives in a mid-stage clinical trial [1] Company Summary - The company is advancing its research in the treatment of narcolepsy, indicating progress in its drug development pipeline [1]